0000950123-22-002445.txt : 20220214 0000950123-22-002445.hdr.sgml : 20220214 20220214081441 ACCESSION NUMBER: 0000950123-22-002445 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 EFFECTIVENESS DATE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRV GP II, LLC CENTRAL INDEX KEY: 0001614073 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18419 FILM NUMBER: 22625468 BUSINESS ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001614073 XXXXXXXX 12-31-2021 12-31-2021 false TRV GP II, LLC
Third Rock Ventures 29 Newbury Street, 3rd Floor Boston MA 02116
13F HOLDINGS REPORT 028-18419 N
Kevin Gillis Chief Operating Officer 617-585-2000 /s/ Kevin Gillis Boston MA 02-14-2022 3 2 24181 false 1 028-18439 Mark Levin 2 028-18438 Kevin P. Starr 3 028-18419 Robert I. Tepper
INFORMATION TABLE 2 10266.xml INFORMATION TABLE FOR FORM 13F JOUNCE THERAPEUTICS, INC. COM 481116101 22527 2697829 SH DFND 1,2,3 2697829 0 0 ALLENA PHARMACEUTICALS, INC. COM 018119107 1654 2790964 SH DFND 1,2,3 2790964 0 0